TrialCancer research and treatment2024

A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.

Kyoo Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.